Linlea Armstrong

ORCID: 0000-0002-8191-6429
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genomics and Rare Diseases
  • Genetics and Neurodevelopmental Disorders
  • Neurofibromatosis and Schwannoma Cases
  • Genomic variations and chromosomal abnormalities
  • Autism Spectrum Disorder Research
  • Cancer Genomics and Diagnostics
  • BRCA gene mutations in cancer
  • Prenatal Screening and Diagnostics
  • Vascular Malformations Diagnosis and Treatment
  • Congenital heart defects research
  • Meningioma and schwannoma management
  • Genetic Neurodegenerative Diseases
  • Chromatin Remodeling and Cancer
  • Genetic factors in colorectal cancer
  • Bone Tumor Diagnosis and Treatments
  • Ion channel regulation and function
  • Neuroblastoma Research and Treatments
  • Neurogenetic and Muscular Disorders Research
  • Biomedical Ethics and Regulation
  • Soft tissue tumor case studies
  • Tracheal and airway disorders
  • Connective tissue disorders research
  • Urological Disorders and Treatments
  • Congenital limb and hand anomalies
  • RNA Research and Splicing

University of British Columbia
2015-2024

British Columbia Children's Hospital
2016-2024

IHS Markit (United States)
2024

Vancouver Biotech (Canada)
2024

B.C. Women's Hospital & Health Centre
2013-2023

Children's & Women's Health Centre of British Columbia
2006-2023

BC Cancer Agency
2009-2022

Vancouver General Hospital
2022

University of Siena
2021

Azienda Ospedaliera Universitaria Senese
2021

Whole-exome sequencing has transformed gene discovery and diagnosis in rare diseases. Translation into disease-modifying treatments is challenging, particularly for intellectual developmental disorder. However, the exception inborn errors of metabolism, since many these disorders are responsive to therapy that targets pathophysiological features at molecular or cellular level.To uncover genetic basis potentially treatable we combined deep clinical phenotyping (the comprehensive...

10.1056/nejmoa1515792 article EN New England Journal of Medicine 2016-05-25
Magdalena Koczkowska Tom Callens Yunjia Chen Alicia Gomes Alesha D. Hicks and 95 more Angela Sharp Eric Johns Kim Uhas Linlea Armstrong Katherine A. Bosanko Dusica Babovic‐Vuksanovic Laura Baker Donald Basel Mario Bengala James T. Bennett Chelsea Chambers L. Kate Clarkson Maurizio Clementi Fanny Cortés Mitch Cunningham Daniela D’Agostino Martin B. Delatycki M. Cristina Digilio Laura Dosa Silvia Esposito Stéphanie Fox Mary‐Louise Freckmann Christine Fauth Teresa Giugliano Sandra Giustini Allison L. Goetsch Yael Goldberg Robert Greenwood Cristin Griffis Karen W. Gripp Punita Gupta Eric Haan Rachel K. Hachen Tamara L. Haygarth Concepción Hernández‐Chico Katelyn Hodge Robert J. Hopkin Louanne Hudgins Sandra Janssens Kory Keller Geraldine Kelly‐Mancuso Aaina Kochhar Bruce R. Korf Andrea M. Lewis Jan Liebelt Angie Lichty Robert Listernick Michael J. Lyons Isabelle Maystadt Mayra Martinez Ojeda Carey McDougall Lesley McGregor Daniela Melis Nancy J. Mendelsohn Małgorzata J.M. Nowaczyk June Ortenberg Karin Panzer John Pappas Mary Ella Pierpont Giulio Piluso Valentina Pinna Enikö K. Pivnick Dinel Pond Cynthia M. Powell Caleb Rogers Noa Ruhrman‐Shahar S. Lane Rutledge Veronica Saletti Sarah A. Sandaradura Claudia Santoro Ulrich A. Schatz Allison Schreiber Daryl A. Scott Elizabeth A. Sellars Ruth Sheffer Elizabeth Siqveland John M. Slopis Rosemarie Smith Alberto Spalice David W. Stockton Haley Streff Amy Theos Gail E. Tomlinson Grace Tran Pamela Trapane Eva Trevisson Nicole J. Ullrich Jenneke van den Ende Samantha A. Schrier Vergano Stephanie E Wallace Michael F. Wangler David D. Weaver Kaleb Yohay Elaine H. Zackai Jonathan Zonana

We report 281 individuals carrying a pathogenic recurrent NF1 missense variant at p.Met1149, p.Arg1276, or p.Lys1423, representing three nontruncating hotspots in the University of Alabama Birmingham (UAB) cohort, together identified 1.8% unrelated individuals. About 25% (95% confidence interval: 20.5–31.2%) heterozygous for p.Lys1423 had Noonan-like phenotype, which is significantly more compared with "classic" NF1-affected cohorts (all p < .0001). Furthermore, p.Arg1276 and variants were...

10.1002/humu.23929 article EN Human Mutation 2019-10-09
Maninder Kaur Justin Blair Batsal Devkota Sierra Fortunato Dinah Clark and 92 more Audrey Lawrence Jiwoo Kim Wonwook Do Benjamin Semeo Olivia Katz Devanshi Mehta Nobuko Yamamoto Emma Schindler Zayd Al Rawi Nina Wallace Jonathan J. Wilde Jennifer McCallum Jinglan Liu Dongbin Xu Marie Jackson Stefan Rentas Ahmad Abou Tayoun Zhe Zhang Omar Abdul‐Rahman Bill Allen Moris A. Angula Kwame Anyane‐Yeboa Jesús Argente Pamela Arn Linlea Armstrong Lina Basel‐Salmon Gareth Baynam Lynne M. Bird Daniel E. Bruegger Gaik‐Siew Ch'ng David Chitayat Robin D. Clark Gerald F. Cox Usha Dave Elfrede DeBaere Michael Field John M. Graham Karen W. Gripp Robert M. Greenstein Neerja Gupta Randy Heidenreich Jodi D. Hoffman Robert J. Hopkin Kenneth Lyons Jones Marilyn C. Jones Ariana Kariminejad Jillene Kogan Baiba Lāce J. G. Leroy Sally Ann Lynch Marie McDonald Kirsten Meagher Nancy J. Mendelsohn Ieva Mičule John B. Moeschler Sheela Nampoothiri Kaoru Ohashi Cynthia M. Powell Subhadra Ramanathan Salmo Raskin Elizabeth Roeder Marlène Rio Alan F. Rope Karan Sangha Angela E. Scheuerle Adele Schneider Stavit A. Shalev Victoria Mok Siu Rosemarie Smith Cathy A. Stevens Tinatin Tkemaladze John Toimie Helga V. Toriello Anne‐Marie W. Turner Patricia G. Wheeler Susan M. White Terri L. Young Kathleen M. Loomes Mary Pipan Ann T. Harrington Elaine H. Zackai Ramakrishnan Rajagopalan Laura K. Conlin Matthew A. Deardorff Deborah McEldrew Juan Pié Feliciano J. Ramos Antonio Musio Antonie D. Kline Kosuke Izumi Sarah E. Raible Ian D. Krantz

Abstract Cornelia de Lange Syndrome (CdLS) is a rare, dominantly inherited multisystem developmental disorder characterized by highly variable manifestations of growth and delays, upper limb involvement, hypertrichosis, cardiac, gastrointestinal, craniofacial, other systemic features. Pathogenic variants in genes encoding cohesin complex structural subunits regulatory proteins (NIPBL, SMC1A, SMC3, HDAC8, RAD21) are the major pathogenic contributors to CdLS. Heterozygous or hemizygous these...

10.1002/ajmg.a.63247 article EN American Journal of Medical Genetics Part A 2023-06-28

Abstract The role for routine whole genome and transcriptome analysis (WGTA) poor prognosis pediatric cancers remains undetermined. Here, we characterize somatic mutations, structural rearrangements, copy number variants, gene expression, immuno-profiles germline cancer predisposition variants in children adolescents with relapsed, refractory or malignancies who underwent WGTA matched sequencing. Seventy-nine participants a median age at enrollment of 8.8 y (range 6 months to 21.2 y) are...

10.1038/s41467-024-48363-5 article EN cc-by Nature Communications 2024-05-16

Abstract Kabuki syndrome is a multiple congenital anomaly/mental retardation syndrome. This study of had two objectives. The first was to further describe the features. In order do so, clinical geneticists were asked submit cases—providing photographs and completing phenotype questionnaire for individuals in whom they felt diagnosis secure. All submitted cases reviewed by four diagnosticians familiar with agreed upon 48 previously unpublished individuals. Our data on these show that variably...

10.1002/ajmg.a.30340 article EN American Journal of Medical Genetics Part A 2004-12-22

Prompt recognition of a child with cancer predisposition syndrome (CPS) has implications for management, surveillance, genetic counseling, and cascade testing relatives. Diagnosis CPS requires practitioner expertise, access to testing, test result interpretation. This diagnostic process is not accessible in all institutions worldwide, leading missed diagnoses. Advances electronic health technology can facilitate risk assessment.To evaluate the accuracy prediction tool (McGill Interactive...

10.1001/jamaoncol.2021.4536 article EN JAMA Oncology 2021-10-10

Abstract Background Women with mutations in BRCA1 or BRCA2 are at high risk of developing breast cancer and, British Columbia, Canada, offered screening both magnetic resonance imaging (MRI) and mammography to facilitate early detection. MRI is more sensitive than but costly produces false positive results. The purpose this study was calculate the cost-effectiveness for BRCA1/2 mutation carriers a Canadian setting. Methods We constructed Markov model annual carriers, using local data...

10.1186/1471-2407-13-339 article EN cc-by BMC Cancer 2013-07-10

Abstract Background Congenital fibrosis of the extraocular muscles types 1 and 3 (CFEOM1/CFEOM3) are autosomal dominant strabismus disorders that appear to result from maldevelopment ocular nuclei nerves. We previously reported most individuals with CFEOM1 rare CFEOM3 harbor heterozygous mutations in KIF21A . encodes a kinesin motor involved anterograde axonal transport, familial de novo date predictably alter one only few amino acids – three within third coiled-coil region stalk distal...

10.1186/1471-2156-8-26 article EN cc-by BMC Genomic Data 2007-05-18

Abstract Episodic Ataxia Type 1 is an autosomal dominant disorder characterized by episodes of ataxia and myokymia. It associated with mutations in the KCNA1 voltage‐gated potassium channel gene. In present study, we describe a family novel clinical features including persistent cerebellar dysfunction, atrophy, cognitive delay. All affected members have myokymia epilepsy, but only one individual has vertigo. Additional include postural abnormalities, episodic stiffness weakness. A mutation...

10.1002/mds.22467 article EN Movement Disorders 2009-02-09

Lynch syndrome is defined by the presence of germline mutations in mismatch repair (MMR) genes. Several models have been recently devised that predict mutation carrier status (Myriad Genetics, Wijnen, Barnetson, PREMM and MMRpro models). Families at moderate-high risk for harboring a Lynch-associated mutation, referred to BC Cancer Agency (BCCA) Hereditary Program (HCP), underwent analysis, immunohistochemistry and/or microsatellite testing. Seventy-two tested cases were included....

10.1002/ijc.24808 article EN International Journal of Cancer 2009-08-03

Genome-wide sequencing (GWS) is a standard of care for diagnosis suspected genetic disorders, but the proportion patients found to have pathogenic or likely variants ranges from less than 30% more 60% in reported studies. It has been suggested that diagnostic rate can be improved by interpreting genomic context each affected individual's full clinical picture and regular follow-up reinterpretation GWS laboratory results. Trio exome was performed 415 families trio genome 85 CAUSES study. The...

10.1016/j.xhgg.2022.100108 article EN cc-by-nc-nd Human Genetics and Genomics Advances 2022-04-19

Abstract The characteristic sites of Neurofibromatosis 1‐associated osseous manifestations are the long bones (usually tibia and fibula), vertebrae sphenoid wing. Although these focal bony lesions may cause profound clinical consequences, a minority people with NF1 affected. However, most shorter than expected for their age, gender family. pathogenesis osteopathy its relationship, if any, to short stature unknown. We examined associations between occurrence various in 3377 probands from...

10.1002/ajmg.a.31754 article EN American Journal of Medical Genetics Part A 2007-05-15

Abstract The neonate born small for gestational age (SGA, birth weight &lt;10th centile) with severe hypospadias, and without the presence of other malformations, is a presentation which clinical geneticists are asked to assess. However, this combination not well addressed in literature. Epidemiological studies point an increased incidence severity hypospadias SGA infants, but leave open possibility that association attributable population subset who have multiple congenital abnormalities or...

10.1002/ajmg.a.36050 article EN American Journal of Medical Genetics Part A 2013-08-02

Identifying genetic mosaicism is important in establishing a diagnosis, assessing recurrence risk, and providing accurate counseling. Next-generation sequencing has allowed for the identification of at levels below those detectable by conventional Sanger or chromosomal microarray analysis. The CAUSES Clinic was pediatric translational trio-based genome-wide (exome genome) study 500 families (531 children) with suspected disease BC Children's Women's Hospitals. Here we present 12 cases...

10.1101/mcs.a006125 article EN Molecular Case Studies 2021-10-25

Abstract People with neurofibromatosis 1 (NF1) have low bone mineralization, but the natural history and pathogenesis are poorly understood. We performed a sibling‐matched case–control study of mineral status, morphology, metabolism. Eighteen children NF1 without focal bony lesions were compared to unaffected siblings local population controls. Bone content at lumbar spine proximal femur (dual energy X‐ray absorptiometry (DXA)) was lower in NF1; this difference persisted after adjusting for...

10.1002/ajmg.a.36001 article EN American Journal of Medical Genetics Part A 2013-05-25
Coming Soon ...